Cita APA

Taxonera, C., Rodriguez, C., Bertoletti, F., Menchen, L., Arribas, J., Sierra, M., . . . Alba, C. (2017). Clinical Outcomes of Golimumab as First, Second or Third Anti-TNF Agent in Patients with Moderate-to-Severe Ulcerative Colitis.

Citación estilo Chicago

Taxonera, C., et al. Clinical Outcomes of Golimumab As First, Second or Third Anti-TNF Agent in Patients With Moderate-to-Severe Ulcerative Colitis. 2017.

Cita MLA

Taxonera, C., et al. Clinical Outcomes of Golimumab As First, Second or Third Anti-TNF Agent in Patients With Moderate-to-Severe Ulcerative Colitis. 2017.